# Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer

> **NCT00900081** · — · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Cervical Cancer
- Precancerous Condition

## Interventions

- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **OTHER:** medical chart review

## Key facts

- **NCT ID:** NCT00900081
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2003-05
- **Primary completion:** 2003-05
- **Final completion:** 2003-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no accrual, PI left institution
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00900081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00900081, "Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00900081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*